Our TLR9 agonists are based on immunostimulatory sequences, or ISS, which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
我们的TLR9显效药是基于免疫共刺激序列（ISS）的。ISS是一短DNA序列，它提高免疫系统能力来对抗疾病并控制慢性炎症。
We adopt the ISS work station of ink system , so the work station will not broken.
我们移植了墨水系统的工作站的ISS，保证了不烧工作站。
We adopt the ISS work station of ink system , so the work station will not broken.
我们移植了墨水系统的工作站的ISS，保证了不烧工作站。
应用推荐